MedTrace Logo

SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction

NCT05583773 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 336

Last updated 2025-04-08

No results posted yet for this study

Summary

The purpose of this study is to conduct a multicenter, randomized clinical trial to evaluate the effect of "ShengXian-QuYu Decoction" on quality of life , symptoms, and biomarkers in heart failure patients with reduced and mildly reduced ejection fraction.

Conditions

Interventions

DRUG

ShengXian-QuYu Decoction

Specification: 30ml/bag, given twice daily, per oral use.

OTHER

Placebo

Placebo matching ShengXian-QuYu Decoction, 30ml/bag, given twice daily, per oral use.

Sponsors & Collaborators

  • China-Japan Friendship Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-29
Primary Completion
2025-08-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05583773 on ClinicalTrials.gov